Hodgkin's disease presenting below the diaphragm. The experience of the gruppo italiano studio linfomi (GISL)

Haematologica

Volumn 82, Issue 6, 1997, Pages 676-682

  Iannitto, Emilio ^a,f   Accurso, Vincenzo ^a   Federico, Massimo ^b   Vallisa, Daniele ^c   Pieresca, Carla ^d   Gravina, Sebastiano F ^a   Di Costanzo, Francesco ^e   Di Trapani, Rosa ^a   Silingardi, Vittorio ^b   Mariani, Guglielmo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c Divisione di Medicina I   (Italy)

^d IRCCS   (Italy)

^e S MARIA HOSPITAL   (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

Author keywords

Clinical stage; Hodgkin's disease; Prognostic factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PROGNOSIS; SURVIVAL RATE;

ABDOMINAL NEOPLASMS; ADOLESCENT; ADULT; AGED; DIAPHRAGM; FEMALE; HODGKIN DISEASE; HUMANS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROPERITONEAL NEOPLASMS; SPLENIC NEOPLASMS;

EID: 0031441134     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Krikorian JG, Portlock CS, Rosenberg SA, Kaplan HS. Hodgkin's disease, stages I and II occurring below the diaphragm. Cancer 1979; 43:7866-71.
2. Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S. Pattern of presentation Hodgkin disease. Cancer 1993; 71:2062-
3. Krikorian JG, Portlock CS, Mauch PM. Hodgkin's disease presenting below the diaphragm: a review. J Clin Oncol 1986; 4:1551-62.
4. Roos DE, O'Brien PC, Wright J, Willson K. Treatment of subdiaphragmatic Hodgkin's disease: is radiotherapy alone appropriate only for inguino-femoral presentation? Int J Radiat Oncol Biol Phys 1994; 28:683-91.
5. Barret A, Gregor A, McElwain TJ, Peckham MJ. Infradiaphragmatic presentation of Hodgkin's disease. Clin Radiol 1981; 32:221-4.
6. Cionini L, Magrini S, Mungai V, Biti GP, Ponticelli P. Stage I and II Hodgkin's disease presenting in infra-diaphragmatic nodes. Tumori 1982; 68:519-25.
7. Dorreen MS, Wrigley PFM, Jones AE, Shand WS, Stansfeld AG, Lister TA. The management of localised infra-diaphragmatic Hodgkin's disease: experience of a rare clinical presentation at St. Bartholomew's Hospital. Hematol Oncol 1984; 2:349-57.
8. Lanzillo JH, Moylan DJ, Mohiuddin M, Kramer S. Radiotherapy of stage I and II Hodgkin's disease with inguinal presentation. Radiology 1985; 154:213-5.
9. Leibenhaut MH, Hoppe RT, Varghese A, Rosenberg SA. Sub-diaphragmatic Hodgkin's disease: Laparotomy and treatment results in 49 patients. J Clin Oncol 1987; 5:1050-5.
10. Specht L, Nissen NI. Hodgkin's disease stage I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combination. Eur J Haematol 1988; 40:396-402.
11. Givens SS, Fuller LM, Hagemeister FB, Gehan EA. Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisolone. Cancer 1990; 66:69-74.
12. Liew KH, Ding JC, Cruickshank D, Quong GG, Wolf MM, Cooper IA. Infra-diaphragmatic Hodgkin's disease, long term follow-up of a rare presentation. Aust NZJ Med 1991; 21:16-21.
13. Mai DH-W, Peschel RE, Portlock C, Knowlton A, Farber L. Stage I and II sub-diaphragmatic Hodgkin's disease. Cancer 1991; 68:1476-81.
14. Villamor N, Reverter JC, Marti JM, Montserrat E, Rozman C. Clinical features and response to treatment of infradiaphragmatic Hodgkin's disease. Eur J Haematol 1991; 46:38-41.
15. Mason MD, Law M, Ashley S, et al. Infradiaphragmatic Hodgkin's disease. Eur J Cancer 1992; 28:1851-2.
16. Enrici RM, Osti MF, Anselmo AP, et al. Hodgkin's disease stage I and II with exclusive subdiaphragmatic presentation. The experience of the departments of radiation oncology and haematology, University "la Sapienza" of Rome. Tumori 1996; 82:48-52.
17. Mauch P, Greenberg H, Lewin A, Cassady JR, Weichselbaum R, Hellman S. Prognostic factors in patients with subdiaphragmatic Hodgkin's disease. Hematol Oncol 1983; 1:205-14.
18. Gobbi PG, Pieresca C, Frassoldati A, et al. Vinblastine, Bleomycin and Methotrexate chemotherapy plus extended field radiotherapy in early, favourably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi Experience. J Clin Oncol 1996; 14:527-33.
19. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease staging classification. Cancer Res 1971; 31:1860-1.
20. Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 1975; 36:252-9.
21. Gobbi PG, Pieresca C, Cavanna L, et al. CCNU, Vinblastine, Procarbazine and Prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavourable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL). Haematologica 1996; 81:503-12.
22. Gobbi PG, Pieresca C, Federico M, et al. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease: A report from the Italian Lymphoma Study Group. J Clin Oncol 1993; 11:712-9.
23. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. Am Stat Assoc J 1958; 53:457-80.
24. Multani PS, Grossbard ML. Staging laparatomy in the management of Hodgkin's disease: Is it still necessary? The Oncologyst 1996; 1:41-55.
25. Pappa VI, Hussain HK, Reznek RH, et al. Role of image-guided core-needle biopsy in the management of patients with lymphoma. J Clin Oncol 1996; 14:2427-30.
26. de Wit M, Bumann D, Beyer W, Herbst K, Clausen M, Hossfeld DK. Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Ann Oncol 1997; 8(suppl 1):57-60.
27. Wedelin C, Bjorkholm M, Biberfeld P, Holm G, Johansson B. Prognostic factors in Hodgkin's disease with special reference to age. Cancer 1984; 53:1202-8.
28. Tubiana M, Henry-Amar P, Carde JMV, et al. Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group Controlled Trials: 1964-1987. Blood 1989; 73:47-56.
29. Mauch P, Tarbell N, Weinstein H, et al. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol 1988; 6:1576-83.
30. Horning SJ, Hoppe RT, Hancock SL, et al. Vinblastine, bleomycin and methotrexate: an effective adjuvant in favorable Hodgkin's disease. J Clin Oncol 1988; 6:1822-31.
31. Pogliani EM, Lambertenghi Deliliers G, Baldini L, et al. EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavorably presenting Hodgkin's disease. Haematologica 1996; 81:8-14.